SAN
DIEGO, June 26, 2024 /PRNewswire/ -- Element
Biosciences, Inc., a developer of pioneering technologies to
empower science, today announced the additions of two
industry-leading artificial intelligence and portfolio management
experts to its executive team. The appointments will build
Element's leadership as it expands with innovative products and
capabilities.
Element is pleased to announce the appointment of Amirali Kia, PhD, as Vice President of
Artificial Intelligence. Dr. Kia will apply his extensive expertise
in Artificial Intelligence within the Life Sciences sector to
enhance the value of Element's current and future products. His
role will include optimizing the utility of the comprehensive
multi-omic datasets generated by Aviti24.
Element is also appointing Tina
Tian, PhD, as Vice President of Portfolio Management. Since
launching Aviti in 2022, Element has continually released new kits
and chemistries, driving innovation and strong differentiation for
its products. Dr. Tian will continue Element's relentless drive,
taking charge of program and portfolio management.
"The key to Element's success and market growth is our
passionate and high-performing team who pushes the boundary of
innovations. The expertise Amirali and Tina bring to Element will
expedite our work to provide innovative products for the future of
biology," said Molly He, CEO,
Element Biosciences. "We will continue to redefine what is possible
on a sequencer and help labs around the globe shift their science
into a higher gear."
About Amirali Kia, PhD, Vice
President of Artificial Intelligence
Amirali brings over 12 years of expertise in applying machine
learning and data science to biology and biotechnology. He has
published numerous articles in the fields of machine learning and
computational biology.
Before joining Element Biosciences, he served as the Vice
President of AI and Data Science at Deepcell, where he helped
expand the company's AI research initiatives in cell morphology.
Prior to this, he was the Vice President of AI and Computational
Biology at Harbinger Health, where he played a pivotal role in
establishing the AI infrastructure and developing algorithms for
early cancer detection in blood samples.
Amirali began his industrial career at Illumina following the
completion of his PhD. As the Director of the Core-AI team, he
successfully harnessed AI for various core technologies at
Illumina, ranging from instrument analysis algorithms to protein
engineering. His extensive industrial experience encompasses tools
and instruments, large molecule discovery, and diagnostics.
Amirali holds a PhD from Stanford
University in High Performance Computing, with a focus on
its applications in biology.
About Tina Tian, PhD, Vice
President of Portfolio Management
Tina brings over 25 years of management experience in the
biotech industry across the areas of portfolio management, program
management, R&D and CLIA laboratory management.
Prior to joining Element, Tina was the Head of Pharma Services
at Roche Diagnostics, leading a cross-functional CLIA team to
provide cutting-edge clinical services to pharma customers. Before
joining Roche, Tina was a Senior Director of Portfolio and Program
Management at Thermo Fisher Scientific's Clinical Sequencing
Division, where she played a pivotal role in building product
roadmaps, establishing a PMO team as well as delivering products to
customers. Tina's experience also includes senior PMO roles at
Pacific Biosciences and Affymetrix.
Tina holds a Ph.D. in Biochemistry from the Johns Hopkins Medical School and received her
postdoctoral training from the National Institutes of Health.
About Element Biosciences, Inc.
Element Biosciences is a pioneering life science company
democratizing access to advanced biological tools, driving
impactful discoveries to benefit humanity. We are focused on
developing disruptive DNA sequencing and multi-omics technology for
research markets. Through innovating every fundamental element of a
biological assay system, Element empowers customers with
affordable, high-quality data and an improved user experience,
which in turn will accelerate scientific discoveries. To learn more
about Element, please visit www.elementbiosciences.com and
follow us on LinkedIn, X (Twitter), and Facebook.
Media Contact:
Melissa Musiker
Element Biosciences
Melissa.Musiker@elembio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/element-biosciences-fortifies-its-executive-team-with-experts-in-artificial-intelligence-and-product-development-302182417.html
SOURCE Element Biosciences